Literature DB >> 786433

Bleeding in renal failure: a possible cause.

M Kazatchkine, Y Sultan, J P Caen, J Bariety.   

Abstract

Increased concentrations of factor VIII-related antigen (VIIIRA), factor VIII-procoagulant activity (VIIC), and decreased factor VII-von Willebrand activity (VIIIVWF) were found in the plasma of patients with chronic renal failure (CRF). This functional abnormality of the factor VII protein may partly explain the prolonged bleeding time commonly found in CRF. It was not improved by dialysis, but it was no longer found in patients with normally functioning grafted kidneys after the sixth month after transplantation. VIIIVWF levels remained decreased when compared with VIIIRA or VIIIC in transplanted patients undergoing acute reversible rejection soon after transplantation. Yet, not only VIIIC and VIIIRA but also VIIIVWF were greatly increased in patients with hyperacute irreversible rejection. Possibly a high VIIIVWF level in these patients is a thrombogenic factor.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 786433      PMCID: PMC1688205          DOI: 10.1136/bmj.2.6036.612

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  10 in total

1.  Subunit structure of factor VIII antigen synthesized by cultured human endothelial cells.

Authors:  E A Jaffe; R L Nachman
Journal:  J Clin Invest       Date:  1975-09       Impact factor: 14.808

2.  The bleeding disorder of uraemia. A qualitative platelet defect.

Authors:  P A Castaldi; M C Rozenberg; J H Stewart
Journal:  Lancet       Date:  1966-07-09       Impact factor: 79.321

3.  Immunological characterization of purified anti-haemophilic factor A (factor VIII) which corrects abnormal platelet retention in Von Willebrand's disease.

Authors:  B N Bouma; Y Wiegerinck; J J Sixma; J A Van Mourik; I A Mochtar
Journal:  Nat New Biol       Date:  1972-03-29

4.  AHF related protein in clinical praxis.

Authors:  L Holmberg; I M Nilsson
Journal:  Scand J Haematol       Date:  1974

5.  Further studies on the platelet-inhibitory effect of guanidinosuccinic acid and its role in uremic bleeding.

Authors:  H I Horowitz; I M Stein; B D Cohen; J G White
Journal:  Am J Med       Date:  1970-09       Impact factor: 4.965

6.  Detection of heterozygotes in both parents of homozygous patients with Von Willebrand's disease.

Authors:  Y Sultan; J Simeon; J P Caen
Journal:  J Clin Pathol       Date:  1975-04       Impact factor: 3.411

7.  Letter: Factor-VIII complex and endothelial damage.

Authors:  B Boneu; M Abbal; J Plante; R Bierme
Journal:  Lancet       Date:  1975-06-28       Impact factor: 79.321

8.  Studies on the purification and characterization of human factor 8.

Authors:  S L Marchesi; N R Shulman; H R Gralnick
Journal:  J Clin Invest       Date:  1972-08       Impact factor: 14.808

9.  Immunofluorescent localization of antihemophilic factor antigen and fibrinogen in human renal diseases.

Authors:  J R Hoyer; A F Michael; L W Hoyer
Journal:  J Clin Invest       Date:  1974-05       Impact factor: 14.808

10.  A clinical and experimental study of platelet function in chronic renal failure.

Authors:  E P Evans; R A Branch; A L Bloom
Journal:  J Clin Pathol       Date:  1972-09       Impact factor: 3.411

  10 in total
  16 in total

1.  Bleeding in renal failure: a possible cause.

Authors:  R P Nerrmann; L R Marshall; P E Hurst
Journal:  Br Med J       Date:  1977-06-18

2.  Factor VIII--related protein on vascular intima of patients with chronic renal failure and prolonged bleeding times.

Authors:  G Remuzzi; T Bertani; G Mecca; M B Donati; G de Gaetano
Journal:  Br Med J       Date:  1978-01-14

3.  Bleeding in renal failure: is von Willebrand factor implicated?

Authors:  G Remuzzi; M Livio; M C Roncaglioni; G Mecca; M B Donati; G de Gaetano
Journal:  Br Med J       Date:  1977-08-06

4.  Factor VIII and chronic renal failure.

Authors:  Z M Ruggeri; C Ponticelli; P M Mannucci
Journal:  Br Med J       Date:  1977-04-23

5.  Factor VIII complex in uraemia and effects of haemodialysis.

Authors:  J H Turney; H F Woods; M R Fewell; M J Weston
Journal:  Br Med J (Clin Res Ed)       Date:  1981-05-23

6.  Transcatheter embolization in the management of intractable uremic epistaxis.

Authors:  R F Gagnon; B Ballermann; P Bourgouin; M J Herba; M Kaye
Journal:  Can Med Assoc J       Date:  1982-01-15       Impact factor: 8.262

7.  Fibreoptic bronchoscopy and diagnosis of pulmonary lesions in lymphoma and leukaemia.

Authors:  M J Phillips; R K Knight; M Green
Journal:  Thorax       Date:  1980-01       Impact factor: 9.139

8.  Coagulation factors as biological risk markers of endothelial dysfunction. Association with the thrombotic episodes of chronic hemodialysis patients.

Authors:  A Sioulis; P Malindretos; A Makedou; P Makris; D Grekas
Journal:  Hippokratia       Date:  2009-10       Impact factor: 0.471

9.  Two cases of the nephrotic syndrome with a reversible coagulation defect.

Authors:  M R Baker; J A Davies; G M Tate; M R Lee
Journal:  Postgrad Med J       Date:  1979-10       Impact factor: 2.401

Review 10.  Critical care in uraemic children.

Authors:  J U Leititis; M Brandis
Journal:  Pediatr Nephrol       Date:  1992-01       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.